{
    "2020-04-30": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Danaher (DHR) Expected to Beat Earnings Estimates: Should You Buy?",
                "features": {
                    "keywords": [
                        "Danaher",
                        "earnings estimates",
                        "beat",
                        "buy"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Can Danaher (DHR) Keep the Earnings Surprise Streak Alive?",
                "features": {
                    "keywords": [
                        "Danaher",
                        "earnings surprise",
                        "streak"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition",
                "features": {
                    "keywords": [
                        "Danaher",
                        "sale",
                        "Sartorius AG",
                        "regulatory requirement",
                        "Cytiva acquisition"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}